Fibrin Sealant Used in EVAR as Filling Technique Treating Abdominal Aortic Aneurysm

A Multi-centerClinical Trial for Fibrin Sealant Used in EVAR as Filling Technique Treating Abdominal Aortic Aneurysm

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023323

Enrollment

Unknown

Registered

2019-05-22

Start date

2019-06-03

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Interventions

Experimental group:Fibrin sealant+operation

Control group:operation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged from 18 to 80, male or female; 2. diagnostic abdominal aortic aneurysm; 3. need endovascular aneurysm repair; 4. good compliance with the instructions and cooperate with follow-up; 5. voluntarily signed the informed conscentform.

Exclusion criteria

Exclusion criteria: 1. Pregnant female; 2. no appropriate vesselapproaches; 3. patients with connective tissue diseases and inflammation disease (such as Marfansyndrome); 4. allergic to blood product or contrast medium; 5. bad compliance with the instructions and follow-up; 6. Estimated remaining life is less than 12 months.

Design outcomes

Primary

Measure	Time frame
Arterial disease mortality;Reintervention rates;	—

Countries

China

Contacts

Public ContactLu Qing-sheng

Changhai Hospital

luqs@xueguan.net+86 13917292504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026